hdzhl co., ltd

Country:

China (Mainland)

Business Type: Trading Company

Mr.felix
Ms.Tina
Ms.Daisy

Mr.Felix

Tel: +86-13032617415

Ms.Tina

Tel: +86 18231170832

Ms.Daisy

Tel: +86-18630082079

Fax:

City: Handan

Street: china

MaxCard:

Home > Products >

Posaconazole CAS NO.171228-49-2

Posaconazole CAS NO.171228-49-2 CAS NO.171228-49-2

Min.Order: 10 Gram
Payment Terms: T/T,Other

Product Details

Keywords

Posaconazole CAS NO.171228-49-2
171228-49-2; C37H42F2N8O4
171228-49-2,C37H42F2N8O4

Quick Details

ProName: Posaconazole CAS NO.171228-49-2
CasNo: 171228-49-2
Molecular Formula: C37H42F2N8O4
Appearance: powder
Application: Pharmaceutical Intermediates
DeliveryTime: within 2-3 days after payment
PackAge: foil bags, drums or bottles ...
Port: Shanghai
ProductionCapacity: 100 Kilogram/Month
Purity: 99%
Storage: Dry and ventilated
Transportation: sea,air,express
LimitNum: 10 Gram

Superiority

Product Details

Keywords

Posaconazole
Posaconazole,chemical
171228-49-2,C37H42F2N8O4

Quick Details

ProName:Posaconazole
CasNo:171228-49-2
Molecular Formula:C37H42F2N8O4
Appearance:powder
Application:Pharmaceutical Intermediates
DeliveryTime:within 1-2days
PackAge:bag
Port:tianjin port
ProductionCapacity:100 Metric Ton/Month
Purity:99
Storage:dry
Transportation:by air
LimitNum:1 Gram

Superiority

roduct name:	posaconazole
synonyms:	posaconazole;2,5-anhydro-1,3,4-trideoxy-2-c-(2,4-difluorophenyl)-4-[[4-[4-[4-[1-[(1s,2s)-1-ethyl-2-hydroxypropyl]-1,5-dihydro-5-oxo-4h-1,2,4-triazol-4-yl]phenyl]-1-piperazinyl]phenoxy]methyl]-1-(1h-1,2,4-triazol-1-yl)-d-threo-pentitol;noxafil;sch 56592;4-[4-[4-[4-[[(3r,5r)-5-(2,4-difluorophenyl)-5-(1,2,4-triazol-1-ylmethyl)oxolan-3-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-2-[(2s,3s)-2-hydroxypentan-3-yl]-1,2,4-triazol-3-one;hydroxypropyl]-2,4-dihydro-3h-1,2,4-triazol-3-one;posaconazole for research;1-((1s,2s)-1-ethyl-2-hydroxypropyl)-4-{4-[4-(4-{[(5s,3r)-5-(2,4-difluorophenyl)-5-(1,2,4-triazolylmethyl)oxolan-3-yl]methoxy}phenyl)piperazinyl]phenyl}-1,2,4-triazolin-5-one
cas:	171228-49-2
mf:	c37h42f2n8o4
mw:	700.78
einecs:	200-659-6
product categories:	chiral reagents;intermediates & fine chemicals;pharmaceuticals;api;noxafil;inhibitors

Details

Posaconazole Usage And Synthesis

Pharmacological effects	Posaconazole (posaconazole) is derived from itraconazole. It is currently subject to III phase clinical trials. Its pharmacological effects are similar with azoles, but compared with itraconazole, it has a stronger inhibitory effect on the C14 demethylation of steroid, especially for Aspergillus.
Pharmacokinetics	Studies on dosage and dosage protocol have shown that the rate of absorption and elimination rate is in line with the single-compartment model. There are significant differences on the relative bioavailability of different doses of oral suspension. It can be taken separately (every 12 hours or every 6 hours) which can significantly improve the bioavailability with the protein binding rate of 98% to 99%. With respect to tablets, the bioavailability of suspensions increase and food can significantly improve the speed and extent of absorption of drug absorption. An investigation of renal dysfunction on the pharmacokinetics of the drug study results has showed that the drug can’t be removed by hemodialysis without being affected by hemodialysis. Single-dose study has showed that patients with varying degrees of chronic kidney disease have no necessity for dosage adjustment. The Half-life of this is about 25 hours which can be primarily metabolized by the liver.
Clinical indications and usage	It can be clinically used for the treatment of aspergillosis, zygnmycosis, and fusariumsis and can also be used for infection caused by part of fluconazole-resistant Candida genus. Studies have shown that posaconazole can widely and effectively applied to the treatment of phaeohyphomycosis and improve the infection survival rate of dermatitidis infection in a dose-dependent manner. The drug, as second-line drugs, has an effective rate of 44% to 78% against the invasive aspergillosis which is resistant to amphotericin B and itraconazole. It also has an effective rate of 71% against the zygomycete fungi. The drug is an oral suspension with the recommended dose of 200mg and 4 times per day with meals and taken orally for 7 to 10 days. This dose can also be maintained or changed to 400mg with oral administration of 2 times per day. The steady-state plasma concentration can reach within 7 to 10 days. The above information is edited by the Chemicalbook of Dai Xiongfeng.
Chemical Properties	White Solid
Usage	Orally active triazole antifungal.
Usage	Posaconazole is a sterol C14ɑ demethylase inhibitor with an IC50 of 0.25 nM

Details

HDZHL CO., LTD.who registered capital of 10 million yuan, nearly to $2 million, we have a pharmaceutical raw materials factory production of pharmaceutical raw materials, and a reagent r&d center, and we do research and development production of reagent tens of thousands of species.

Our company is honored as the high-tech enterprise which engaged in researching, developing, manufacturing and exporting research chemicals,advanced pharmaceutical intermediates and Active Pharmaceutical Ingredients (API), include kinds of research chemicals, We have own labs to do research,we provide many kinds of research chemicals.

We have established a broad customer base in America, Australia,Russia and other European countries, We have built many long business relationship with our customers.

We base our goods with all our power so it will definitely meet and surpass every buyer's highest expectations. We guarantee that after purchasing from us , you will never look anywhere else again!

hdzhl co., ltd

Posaconazole CAS NO.171228-49-2

Posaconazole CAS NO.171228-49-2 CAS NO.171228-49-2

Keywords

Quick Details

Superiority

Keywords

Quick Details

Superiority

Details

Details

Other products of this supplier